Townsend Asset Management Corp Pfizer Inc Transaction History

Townsend Asset Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $41,833 - $54,609	1,002 Added 21.14%	5,742 $294,000
Q2 2022 Jul 25, 2022	BUY	$46.53 - $55.17 $220,552 - $261,505	4,740 New	4,740 $249,000
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $224,129 - $277,724	-4,899 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $6,404 - $9,493	155 Added 3.27%	4,899 $289,000
Q3 2021 Oct 21, 2021	BUY	$39.25 - $50.42 $186,202 - $239,192	4,744 New	4,744 $204,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Townsend Asset Management Corp , based on Form 13F filings with the SEC.

Stay updated on Townsend Asset Management Corp with notifications on news.